Search for: "Orion Home Systems LLC"
Results 1 - 6
of 6
Sorted by Relevance
|
Sort by Date
28 Aug 2009, 8:11 am
Warner Home Video (antitrust litigation) 8/19: Telecommunication Systems Inc. v. [read post]
5 Apr 2010, 8:49 pm
Orion IP, LLC sued Hyundai for infringing a patented method for generating customized product proposals for potential customers of an automobile dealer (U.S. [read post]
16 Nov 2007, 4:00 am
: (IP Dragon),Adidas-Salamon AG recently won a suit for unfair competition in China against two Chinese footwear manufacturing companies: (Post Grant Opposition),Patent litigation in China: (Ladas & Parry), (Philip Brooks), DenmarkLego loses trade mark case at home in Denmark: (IPFactor), EuropeThe battle for Magenta and colour marks in Europe: (IPKat), (richlicki), EPO Board of Appeals cases database updated: (EPO), Will the EU Community Patent get a final chance? [read post]
1 Jun 2010, 11:05 pm
United States (Gray on Claims) CAFC: Orion v Hyundai on novelty: Expanding the scope of a printed publication with oral testimony (Patently-O) District Court N D Illinois: False marking includes marking with expired patent number: ZOJO Solutions Inc. v. [read post]
13 Feb 2009, 8:00 am
(Afro-IP) New Zealand Haka war dance now covered by intellectual property (Techdirt) Nigeria Nigerian musicians want payment for music played on airplanes (Afro-IP) Poland PARIS-DAKAR seeks to invalidate world trade mark registration for DAKAR by Polish company by the same name (Class 46) South Africa Delays at the SA registry favour trade mark proprietor: Golden Fried Chicken (Pty) Ltd v Soulsa CC (Afro-IP) Spain Exhaustion of trade mark rights… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
